Drug-induced hypersensitivity syndrome and toxic epidermal necrolysis. Treatment with N-acetylcysteine [13]

British Journal of Dermatology

Volumn 136, Issue 4, 1997, Pages 645-646

  Redondo, P ^a   De Felipe, I ^a   De La Pena, A ^a   Aramendia, J M ^a   Vanaclocha, V ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTICONVULSIVE AGENT; CORTICOSTEROID; SULFONAMIDE;

ADULT; CASE REPORT; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LETTER; PRIORITY JOURNAL; TOXIC EPIDERMAL NECROLYSIS;

EID: 0030993825     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1997.tb02175.x     Document Type: Letter

References (16)

1. 1 Mauri‐Hellweg D, Bettens F, Mauri D et al. Activation of drugspecific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin and carbamazepine. J Immunol 1995 ; 155: 462–72.
2. 2 Vittorio CC. Muglia JJ. Anticonvulsant hypersensitivity syndrome. Arch Intern Med 1995 ; 155: 2285–90.
3. 3 Heimbach DM. Engrav LH. Marvin JA et al. Toxic epidermal necroiysis: a step forward in treatment. JAMA 1987 ; 257: 2171–5.
4. 4 Handfieid‐Jones SE. Jenkins RE. Whittaker SJ et al. The anticonvulsant hypersensitivity syndrome. Br J Dermatol 1993 ; 129: 175–7.
5. 5 Cockey GH. Amann ST. Reents SB. Lynch JW Jr. Stevens‐Johnson syndrome resulting from whole‐brain radiation and phenytoin. Am J Clin Oncol 1996 ; 19: 32–4.
6. 6 Dröge W. Eck H‐P. Mihm S. HIV‐induced cysteine deficiency and T‐cell dysfunction—a rationale for treatment with N‐acetylcysteine. Immunol Today 1992 ; 13: 211–14.
7. 7 Shear NH. Spielberg SP. Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. J clin Invest 1988 ; 82: 826–32.
8. 8 Van der Ven AJAM. Koopmans PP. Vree TB. Van der Meer JWM. Adverse reactions to co‐trimoxazole in HIV infection. Lancet 1991 ; 338: 431–3.
9. 9 Mihm S. Ennen J. Pessara V et al. Inhibition of HIV‐1 replication and NF‐kappa B activity by cysteine and cysteine derivatives. AIDS 1991 ; 5: 497–503.
10. 10 Ullman KS. Northrop JJ. Werweig CL. Crabtrer GR. Transmission of signals from the lymphocyte antigen receptor to the genes 18 responsible for cell proliferation and immune function: the missing link. Annu Rev Immunol 1990 ; 8: 421–52.
11. 11 Redondo P. Subira ML. N‐acetylcysteine inhibits production of tumor necrosis factor‐α and interleukin‐1;β. Arch Intern Med 1996 ; 156: 1238–41.
12. 12 Paquet P. Nikkels A. Arrese JE et al. Macrophages and tumor necrosis factor‐alpha in toxic epidermal necrolysis. Arch Dermatol 1994 ; 130: 605–8.
13. 13 Redondo P. Ruiz de Erenchun F. Monedero P et al. Toxic epidermal necrolysis. Treatment with pentoxifylline. Br J Dermatoi 1994 ; 130: 688–9.
14. 14 Senaldi G. Pointare E Piguet P‐F. Grau GE. Protective effect of N acetylcysteine in hapten‐induced irritant and contact hypersensitivity reactions. J Invest Dermatol 1994 ; 102: 934–7.
15. 15 Ikeda M. Scbroeder KK. Mosher LB et al. Suppressive effect of antioxidants on intercellular adhesion molecule‐1 (ICAM‐1) expression in human epidermal keratinocytes. J Invest Dermatol 1994 ; 103: 791–6.
16. 16 Burgunder JM. Varriale A. Lauterburg BH. Effect of N‐acetylcysteine on plasma cysteine and glutathione following paracetamol administration. Eur J Clin Pharmacol 1989 ; 36: 127–31.